GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Pparg | affects activity | ISO | Pparg (Rattus norvegicus) | 6480464 | CTD | Cyclosporine affects the activity of PPARG protein | PMID:25596134 | Pparg | affects activity | ISO | PPARG (Homo sapiens) | 6480464 | CTD | Cyclosporine affects the activity of PPARG protein | PMID:25596134 | Pparg | decreases expression | ISO | Pparg (Rattus norvegicus) | 6480464 | CTD | Cyclosporine results in decreased expression of PPARG mRNA; Cyclosporine results in decreased expression of PPARG protein | PMID:17461532 | Pparg | increases expression | ISO | PPARG (Homo sapiens) | 6480464 | CTD | Cyclosporine results in increased expression of PPARG mRNA | PMID:20106945 | Pparg | multiple interactions | ISO | Pparg (Rattus norvegicus) | 6480464 | CTD | Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]; rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG mRNA]; rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG protein] | PMID:17461532 | Pparg | multiple interactions | ISO | PPARG (Homo sapiens) | 6480464 | CTD | [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein | PMID:17016853 | |
Go Back to source page | Continue to Ontology report |